For example, a variety of drugs, such as sodium-glucose cotransporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 (GLP-1), can be used for the treatment of DN. The gene discussed is GCG; the disease is liver dysplastic nodule.